Compare CGEN & BHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CGEN | BHR |
|---|---|---|
| Founded | 1993 | 2013 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.7M | 195.8M |
| IPO Year | 2000 | N/A |
| Metric | CGEN | BHR |
|---|---|---|
| Price | $1.74 | $2.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 568.8K | 403.7K |
| Earning Date | 03-03-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 6.64% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,903,000.00 | ★ $710,399,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $164.92 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.13 | $1.80 |
| 52 Week High | $2.66 | $3.28 |
| Indicator | CGEN | BHR |
|---|---|---|
| Relative Strength Index (RSI) | 42.09 | 54.89 |
| Support Level | $2.04 | $2.64 |
| Resistance Level | $2.08 | $3.13 |
| Average True Range (ATR) | 0.12 | 0.14 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 1.00 | 57.66 |
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury, upper-upscale and upscale hotels in gateway and resort locations. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment of the hotel lodging industry. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and, among others.